AAAAAA

   
Results: 1-23 |
Results: 23
PROVIRAL STRUCTURE, CHROMOSOMAL LOCATION, AND EXPRESSION OF HERV-K-T47D, A NOVEL HUMAN ENDOGENOUS RETROVIRUS DERIVED FROM T47D PARTICLES
Authors: SEIFARTH W BAUST C MURR A SKLADNY H KRIEGSCHNEIDER F BLUSCH J WERNER T HEHLMANN R LEIBMOSCH C
Citation: W. Seifarth et al., PROVIRAL STRUCTURE, CHROMOSOMAL LOCATION, AND EXPRESSION OF HERV-K-T47D, A NOVEL HUMAN ENDOGENOUS RETROVIRUS DERIVED FROM T47D PARTICLES, Journal of virology, 72(10), 1998, pp. 8384-8391
MOLECULAR RESPONSE OF CML PATIENTS TREATED WITH INTERFERON-ALPHA MONITORED BY QUANTITATIVE SOUTHERN BLOT ANALYSIS
Authors: REITER A SKLADNY H HOCHHAUS A SEIFARTH W HEIMPEL H BARTRAM CR CROSS NCP HEHLMANN R
Citation: A. Reiter et al., MOLECULAR RESPONSE OF CML PATIENTS TREATED WITH INTERFERON-ALPHA MONITORED BY QUANTITATIVE SOUTHERN BLOT ANALYSIS, British Journal of Haematology, 97(1), 1997, pp. 86-93
DETECTION OF ASPERGILLUS SPECIES BY PCR IN BLOOD AND BRONCHOALVEOLAR LAVAGE SAMPLES OF FEBRILE NEUTROPENIC PATIENTS
Authors: BUCHHEIDT D SKLADNY H BAUST C HEHLMANN R
Citation: D. Buchheidt et al., DETECTION OF ASPERGILLUS SPECIES BY PCR IN BLOOD AND BRONCHOALVEOLAR LAVAGE SAMPLES OF FEBRILE NEUTROPENIC PATIENTS, Blood, 90(10), 1997, pp. 597-597
RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS CHEMOTHERAPY IN PATIENTSWITH PHILADELPHIA-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: HOCHHAUS A HEHLMANN R BARTRAM CR HEIMPEL H REITER A BERGER U ANSARI H SKLADNY H HEINZE B HOSSFELD DK
Citation: A. Hochhaus et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS CHEMOTHERAPY IN PATIENTSWITH PHILADELPHIA-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 2298-2298
COMPARISON OF MOLECULAR METHODS TO MONITOR RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS TREATED WITH INTERFERON-ALPHA
Authors: HOCHHAUS A REITER A SKLADNY H LIN F HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., COMPARISON OF MOLECULAR METHODS TO MONITOR RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS TREATED WITH INTERFERON-ALPHA, Experimental hematology, 24(9), 1996, pp. 578-578
LEVELS OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS IN COMPLETE CYTOGENETIC REMISSION AFTER INTERFERON-ALPHA-THERAPY CORRELATE WITH RISK OF RELAPSE
Authors: HOCHHAUS A LIN F REITER A SKLADNY H SHEPHERD PCA SILL H ALLAN NC HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., LEVELS OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS IN COMPLETE CYTOGENETIC REMISSION AFTER INTERFERON-ALPHA-THERAPY CORRELATE WITH RISK OF RELAPSE, Experimental hematology, 24(9), 1996, pp. 579-579
QUANTITATIVE MOLECULAR METHODS TO MONITOR THE RESPONSE OF CML PATIENTS TO INTERFERON-ALPHA
Authors: HOCHHAUS A LIN F REITER A SKLADNY H HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., QUANTITATIVE MOLECULAR METHODS TO MONITOR THE RESPONSE OF CML PATIENTS TO INTERFERON-ALPHA, Bone marrow transplantation, 17, 1996, pp. 41-44
A NOVEL BCR-ABL, FUSION GENE (E6A2) IN A PATIENT WITH PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA
Authors: HOCHHAUS A REITER A SKLADNY H MELO JV SICK C BERGER U GUO JQ ARLINGHAUS RB HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., A NOVEL BCR-ABL, FUSION GENE (E6A2) IN A PATIENT WITH PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA, Blood, 88(6), 1996, pp. 2236-2240
QUANTITATIVE SOUTHERN BLOT AND COMPETITIVE POLYMERASE CHAIN-REACTION ARE COMPLEMENTARY METHODS TO MONITOR RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS ON INTERFERON-ALPHA THERAPY
Authors: HOCHHAUS A REITER A SKLADNY H LIN F SAUSSELE S REICHERT A HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., QUANTITATIVE SOUTHERN BLOT AND COMPETITIVE POLYMERASE CHAIN-REACTION ARE COMPLEMENTARY METHODS TO MONITOR RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS ON INTERFERON-ALPHA THERAPY, Blood, 88(10), 1996, pp. 2289-2289
MOLECULAR HETEROGENEITY IN COMPLETE CYTOGENETIC RESPONDERS AFTER INTERFERON-ALPHA-THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA - LEVELS OF MINIMAL RESIDUAL DISEASE PREDICT RISK OF RELAPSE
Authors: HOCHHAUS A REITER A SKLADNY H LIN F REICHERT A SAUSSELE S SHEPHERD PCA ALLAN NC HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., MOLECULAR HETEROGENEITY IN COMPLETE CYTOGENETIC RESPONDERS AFTER INTERFERON-ALPHA-THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA - LEVELS OF MINIMAL RESIDUAL DISEASE PREDICT RISK OF RELAPSE, Blood, 88(10), 1996, pp. 2644-2644
QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS ON INTERFERON-ALPHA THERAPY BY COMPETITIVE POLYMERASE CHAIN-REACTION
Authors: HOCHHAUS A LIN F REITER A SKLADNY H MASON PJ VANRHEE F SHEPHERD PCA ALLAN NC HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS ON INTERFERON-ALPHA THERAPY BY COMPETITIVE POLYMERASE CHAIN-REACTION, Blood, 87(4), 1996, pp. 1549-1555
ENDOGENOUS RETROVIRAL SEQUENCES FROM PARTICLES RELEASED BY A HUMAN BREAST-CARCINOMA CELL-LINE
Authors: LEIBMOSCH C SEIFARTH W SKLADNY H KRIEGSCHNEIDER F HEHLMANN R
Citation: C. Leibmosch et al., ENDOGENOUS RETROVIRAL SEQUENCES FROM PARTICLES RELEASED BY A HUMAN BREAST-CARCINOMA CELL-LINE, AIDS research and human retroviruses, 11, 1995, pp. 70-70
MONITORING THE EFFICIENCY OF INTERFERON-ALPHA THERAPY IN CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS BY COMPETITIVE POLYMERASE CHAIN-REACTION
Authors: HOCHHAUS A LIN F REITER A SKLADNY H VANRHEE F SHEPHERD PCA ALLAN NC HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., MONITORING THE EFFICIENCY OF INTERFERON-ALPHA THERAPY IN CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS BY COMPETITIVE POLYMERASE CHAIN-REACTION, Experimental hematology, 23(8), 1995, pp. 791-791
MOLECULAR MONITORING OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA ONINTERFERON-ALPHA THERAPY BY QUANTITATIVE SOUTHERN BLOT
Authors: REITER A SKLADNY H HOCHHAUS A HEHLMANN R
Citation: A. Reiter et al., MOLECULAR MONITORING OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA ONINTERFERON-ALPHA THERAPY BY QUANTITATIVE SOUTHERN BLOT, Experimental hematology, 23(8), 1995, pp. 792-792
ATYPICAL BCR-ABL TRANSCRIPTS IN 2 PATIENTS WITH PHILADELPHIA-CHROMOSOME NEGATIVE CHRONIC MYELOID-LEUKEMIA
Authors: HOCHHAUS A REITER A SKLADNY H ZENHAUSERN R HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., ATYPICAL BCR-ABL TRANSCRIPTS IN 2 PATIENTS WITH PHILADELPHIA-CHROMOSOME NEGATIVE CHRONIC MYELOID-LEUKEMIA, Experimental hematology, 23(8), 1995, pp. 932-932
RETROVIRUS-LIKE PARTICLES RELEASED FROM THE HUMAN BREAST-CANCER CELL-LINE T47-D DISPLAY TYPE-B-RELATED AND TYPE-C-RELATED ENDOGENOUS RETROVIRAL SEQUENCES
Authors: SEIFARTH W SKLADNY H KRIEGSCHNEIDER F REICHERT A HEHLMANN R LEIBMOSCH C
Citation: W. Seifarth et al., RETROVIRUS-LIKE PARTICLES RELEASED FROM THE HUMAN BREAST-CANCER CELL-LINE T47-D DISPLAY TYPE-B-RELATED AND TYPE-C-RELATED ENDOGENOUS RETROVIRAL SEQUENCES, Journal of virology, 69(10), 1995, pp. 6408-6416
VARIABLE NUMBERS OF BCR-ABL TRANSCRIPTS PERSIST IN CML PATIENTS WHO ACHIEVE COMPLETE CYTOGENETIC REMISSION WITH INTERFERON-ALPHA
Authors: HOCHHAUS A LIN F REITER A SKLADNY H VANRHEE F SHEPHERD PCA ALLAN NC HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., VARIABLE NUMBERS OF BCR-ABL TRANSCRIPTS PERSIST IN CML PATIENTS WHO ACHIEVE COMPLETE CYTOGENETIC REMISSION WITH INTERFERON-ALPHA, British Journal of Haematology, 91(1), 1995, pp. 126-131
QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS ON INTERFERON-ALPHA THERAPY BY COMPETITIVE POLYMERASE CHAIN-REACTION
Authors: HOCHHAUS A REITER A SKLADNY H LIN F MASON PJ VANRHEE F SHEPHERD PCA ALLAN NC HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., QUANTIFICATION OF RESIDUAL DISEASE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS ON INTERFERON-ALPHA THERAPY BY COMPETITIVE POLYMERASE CHAIN-REACTION, Blood, 86(10), 1995, pp. 1064-1064
ATYPICAL BCR-ABL TRANSCRIPTS IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS DETECTED BY MULTIPLEX POLYMERASE CHAIN-REACTION
Authors: HOCHHAUS A REITER A MELO JV SKLADNY H SHEPHERD PCA SICK C CLARK RE TOBLER A BELL A HEHLMANN R GOLDMAN JM CROSS NCP
Citation: A. Hochhaus et al., ATYPICAL BCR-ABL TRANSCRIPTS IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS DETECTED BY MULTIPLEX POLYMERASE CHAIN-REACTION, Blood, 86(10), 1995, pp. 2094-2094
COMPARISON BETWEEN CYTOGENETICS AND QUANTITATIVE SOUTHERN BLOT ANALYSIS FOR MONITORING INTERFERON-ALPHA TREATMENT IN CML PATIENTS
Authors: REITER A SKLADNY H HOCHHAUS A SCHULTHEIS B BARTRAM CR HEIMPEL H HEHLMANN R
Citation: A. Reiter et al., COMPARISON BETWEEN CYTOGENETICS AND QUANTITATIVE SOUTHERN BLOT ANALYSIS FOR MONITORING INTERFERON-ALPHA TREATMENT IN CML PATIENTS, Blood, 86(10), 1995, pp. 2097-2097
TRANSCRIPTION PATTERN OF HUMAN ENDOGENOUS RETROVIRUS-K (HERV-K) RELATED ENV SEQUENCES IN PATIENTS WITH CML, NHL COLON-CANCER AND MAMMA CARCINOMA
Authors: WILLER A SAUSSELE S SEIFARTH W SKLADNY H KRIEGSCHNEIDER F KISTER P REITER A LEIBMOSCH C HEHLMANN R
Citation: A. Willer et al., TRANSCRIPTION PATTERN OF HUMAN ENDOGENOUS RETROVIRUS-K (HERV-K) RELATED ENV SEQUENCES IN PATIENTS WITH CML, NHL COLON-CANCER AND MAMMA CARCINOMA, Blood, 86(10), 1995, pp. 2236-2236
CLONING AND CHARACTERIZATION OF THE GENE ENCODING THE MAJOR SIGMA-FACTOR OF STIGMATELLA-AURANTIACA
Authors: SKLADNY H HEIDELBACH M SCHAIRER HU
Citation: H. Skladny et al., CLONING AND CHARACTERIZATION OF THE GENE ENCODING THE MAJOR SIGMA-FACTOR OF STIGMATELLA-AURANTIACA, Gene, 143(1), 1994, pp. 123-127
HEAT-SHOCK AND DEVELOPMENT INDUCE SYNTHESIS OF A LOW-MOLECULAR-WEIGHTSTRESS-RESPONSIVE PROTEIN IN THE MYXOBACTERIUM STIGMATELLA-AURANTIACA
Authors: HEIDELBACH M SKLADNY H SCHAIRER HU
Citation: M. Heidelbach et al., HEAT-SHOCK AND DEVELOPMENT INDUCE SYNTHESIS OF A LOW-MOLECULAR-WEIGHTSTRESS-RESPONSIVE PROTEIN IN THE MYXOBACTERIUM STIGMATELLA-AURANTIACA, Journal of bacteriology, 175(22), 1993, pp. 7479-7482
Risultati: 1-23 |